News

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...
Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...
Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 ...